Clinical Trials
18 trialsNCT07525466 2026-04-13
Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)
Beijing Tongren Hospital
Phase 1/2 Recruiting
NCT05898477 2026-01-22
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
University of Alabama at Birmingham
Recruiting
NCT07270835 2025-12-08
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 4 Recruiting
NCT05236764 2025-10-30
HAPLOTAB
Baylor College of Medicine
Phase NA Active not recruiting
NCT00710892 2025-07-11
CASPALLO
Baylor College of Medicine
Phase 1 Active not recruiting
NCT01494103 2025-07-11
DOTTI
Baylor College of Medicine
Phase 1 Active not recruiting
NCT05702502 2025-04-08
Assessing the Presence of CT-DNA in Lymphoma Associated HLH
Nottingham University Hospitals NHS Trust
Recruiting
NCT06734624 2024-12-16
The Microbiome in Blood Cancer and HLH
University of Nottingham
Not yet recruiting
NCT06585124 2024-09-05
LA-HLH
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT02061800 2024-06-04
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University
Phase 1/2 Active not recruiting
NCT05775705 2023-03-20
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
Beijing Friendship Hospital
Phase 3 Not yet recruiting
NCT05600959 2022-11-01
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
Beijing Friendship Hospital
Unknown
NCT05008666 2021-08-17
Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH
Sun Yat-sen University
Phase 2 Unknown
NCT04999878 2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4 Unknown
NCT04405375 2020-05-28
GPED Regimen for Relapsed/Refractory or Advanced ENKTCL
Beijing Tongren Hospital
Phase 2 Unknown
NCT00368355 2020-01-21
MOHEL
Baylor College of Medicine
Phase 2 Completed
NCT01818908 2019-02-15
Trial of DA-EPOCH Regimen for NHL With HLH
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT01490801 2016-05-17
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
Children's Oncology Group
Completed